US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eterna Therapeutics Inc.

0.3051

-0.0636-17.25%

Post-market: 0.2975-0.0076-2.49%19:49 EST

Volume:1.23M

Turnover:402.47K

Market Cap:8.26M

PE:-0.08

High:0.3565

Open:0.3450

Low:0.2902

Close:0.3687

52wk High:5.17

52wk Low:0.2682

Shares:27.09M

Float Shares:21.64M

Volume Ratio:0.12

T/O Rate:5.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.7603

EPS(LYR):-48.9723

ROE:-2264.31%

ROA:-89.29%

PB:2.32

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Ernexa Therapeutics CEO Sanjeev Luther to Join Virtual Investor Closing Bell Series Webcast

10% Owner Charles Cherington Reports Acquisition of Ernexa Therapeutics Inc. Common Shares

Ernexa Therapeutics Announces Issuance of Warrants in $10.5 Million Public Offering

Ernexa Therapeutics prices 21M shares at 50c in public offering

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering

Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA

Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

BRIEF-Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting

Eterna Therapeutics Expects to Begin First-in-Human Ovarian Cancer Trial in H2

MT Newswires Live

Ernexa Therapeutics Receives FDA Alignment to Advance Ovarian Cancer Cell Therapy Trial

Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

THOMSON REUTERS

Ernexa Therapeutics Inc - on Track to Initiate Fih Trial for Ovarian Cancer in 2026

THOMSON REUTERS

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer

BRIEF-Ernexa Therapeutics Announces Oral Presentation At The 67Th American Society Of Hematology

Ernexa Therapeutics Announces Oral Presentation at the 67TH American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS

Press Release: Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG

Ernexa Therapeutics to Present at Oxford Global’s Cell 2025

Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials

Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform

BRIEF-Cellipont Bioservices And Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership To Advance Erna-101 Toward Clinical Trials In Ovarian Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ERNA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ERNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERNA\",,,,,undefined,":{"symbol":"ERNA","market":"US","secType":"STK","nameCN":"Eterna Therapeutics Inc.","latestPrice":0.3051,"timestamp":1771621200000,"preClose":0.3687,"halted":0,"volume":1231940,"hourTrading":{"tag":"盘后","latestPrice":0.2975,"preClose":0.3051,"latestTime":"19:49 EST","volume":80165,"amount":23960.4206,"timestamp":1771634972496,"change":-0.0076,"changeRate":-0.02491,"amplitude":0.04392},"delay":0,"changeRate":-0.17249796582587482,"floatShares":21644600,"shares":27085100,"eps":-3.760293,"marketStatus":"Market Closed","change":-0.0636,"latestTime":"02-20 16:00:00 EST","open":0.345,"high":0.3565,"low":0.2902,"amount":402470.43693240004,"amplitude":0.179821,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.760293,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":465451200000,"exchange":"NASDAQ","adjPreClose":0.3687,"preHourTrading":{"tag":"盘前","latestPrice":0.3419,"preClose":0.3687,"latestTime":"09:29 EST","volume":96583,"amount":32796.59852198,"timestamp":1771597793748,"change":-0.0268,"changeRate":-0.072688,"amplitude":0.063195},"postHourTrading":{"tag":"盘后","latestPrice":0.2975,"preClose":0.3051,"latestTime":"19:49 EST","volume":80165,"amount":23960.4206,"timestamp":1771634972496,"change":-0.0076,"changeRate":-0.02491,"amplitude":0.04392},"volumeRatio":0.11797244745659041},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERNA\",,,,,undefined,":{"symbol":"ERNA","floatShares":21644600,"roa":"-89.29%","roe":"-2264.31%","lyrEps":-48.972301,"volumeRatio":0.11797244745659041,"shares":27085100,"dividePrice":0,"high":0.3565,"amplitude":0.179821,"preClose":0.3687,"low":0.2902,"week52Low":0.2682,"pbRate":"2.32","psRate":"8263.66","week52High":5.1735,"institutionHeld":0.0702,"latestPrice":0.3051,"eps":-3.760293,"divideRate":0,"volume":1231940,"delay":0,"ttmEps":-3.760293,"open":0.345,"prevYearClose":1.2,"prevWeekClose":0.323,"prevMonthClose":1.22,"prevQuarterClose":1.2,"fiveDayClose":0.3639,"twentyDayClose":1.24,"sixtyDayClose":1.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ERNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-07","symbol":"ERNA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2025-08-13","symbol":"ERNA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.61},{"market":"US","date":"2025-06-12","symbol":"ERNA","defaultRemindTime":1749735000000,"type":"split","dateTimestamp":1749700800000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2025-05-07","symbol":"ERNA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2025-03-12","symbol":"ERNA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ERNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ERNA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ERNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ERNA","date":"2026-02-20","current":-0.081137,"percent":0.436926,"low":-414.27655,"twenty":-0.9593,"median":-0.505819,"eighty":-0.282938,"high":-0.075385,"avg":-5.680998,"sd":24.615677,"marketCap":9986281},"quantilePoints":[{"date":"2021-03-26","current":-25.050283,"twenty":-25.050283,"median":-25.050283,"eighty":-25.050283,"marketCap":197282700},{"date":"2021-04-01","current":-19.76073,"twenty":-22.50489,"median":-19.76073,"eighty":-19.686957,"marketCap":155625000},{"date":"2021-04-09","current":-33.883066,"twenty":-30.637037,"median":-24.82949,"eighty":-19.750191,"marketCap":266845000},{"date":"2021-04-16","current":-41.840053,"twenty":-33.50366,"median":-30.299787,"eighty":-21.44698,"marketCap":329510000},{"date":"2021-04-23","current":-85.155574,"twenty":-42.851802,"median":-31.986036,"eighty":-24.060665,"marketCap":670640000},{"date":"2021-04-30","current":-262.814932,"twenty":-85.482285,"median":-33.883066,"eighty":-24.961966,"marketCap":2069790588},{"date":"2021-05-07","current":-202.916348,"twenty":-203.739624,"median":-41.76101,"eighty":-26.678356,"marketCap":1598061207},{"date":"2021-05-14","current":-113.992019,"twenty":-184.841871,"median":-51.58868,"eighty":-29.656904,"marketCap":897740496},{"date":"2021-05-21","current":-23.451941,"twenty":-172.43288,"median":-41.76101,"eighty":-27.638585,"marketCap":581462452},{"date":"2021-05-28","current":-24.790712,"twenty":-163.283012,"median":-33.883066,"eighty":-24.914666,"marketCap":614655648},{"date":"2021-06-04","current":-27.975629,"twenty":-151.324405,"median":-33.408808,"eighty":-25.008431,"marketCap":693621825},{"date":"2021-06-11","current":-24.618554,"twenty":-136.546035,"median":-31.986036,"eighty":-25.008431,"marketCap":610387206},{"date":"2021-06-18","current":-27.459156,"twenty":-126.674306,"median":-31.4313,"eighty":-25.256072,"marketCap":680816499},{"date":"2021-06-25","current":-32.864909,"twenty":-117.855082,"median":-31.366149,"eighty":-25.558535,"marketCap":814845577},{"date":"2021-07-02","current":-30.0425,"twenty":-97.670284,"median":-31.300997,"eighty":-25.720363,"marketCap":744867381},{"date":"2021-07-09","current":-23.021892,"twenty":-86.135706,"median":-31.005605,"eighty":-25.503445,"marketCap":570799915},{"date":"2021-07-16","current":-17.907896,"twenty":-77.398829,"median":-30.178246,"eighty":-24.852689,"marketCap":444004578},{"date":"2021-07-23","current":-18.282091,"twenty":-60.093699,"median":-28.629829,"eighty":-23.901199,"marketCap":453282285},{"date":"2021-07-30","current":-20.473804,"twenty":-49.712728,"median":-28.247243,"eighty":-21.865619,"marketCap":507623144},{"date":"2021-08-06","current":-20.313434,"twenty":-44.875301,"median":-27.776888,"eighty":-21.432455,"marketCap":503646984},{"date":"2021-08-13","current":-17.513386,"twenty":-41.776819,"median":-27.272265,"eighty":-21.243576,"marketCap":575233152},{"date":"2021-08-20","current":-15.11947,"twenty":-41.218249,"median":-26.736094,"eighty":-20.908583,"marketCap":496604160},{"date":"2021-08-27","current":-18.033118,"twenty":-39.015872,"median":-26.305699,"eighty":-20.349072,"marketCap":592303920},{"date":"2021-09-03","current":-18.663096,"twenty":-36.032611,"median":-25.754795,"eighty":-19.707771,"marketCap":612995760},{"date":"2021-09-10","current":-19.308823,"twenty":-34.735027,"median":-25.393264,"eighty":-19.132429,"marketCap":634204896},{"date":"2021-09-17","current":-18.82059,"twenty":-33.788214,"median":-24.972717,"eighty":-19.025333,"marketCap":618168720},{"date":"2021-09-24","current":-14.930477,"twenty":-33.300028,"median":-24.618554,"eighty":-18.843094,"marketCap":490396608},{"date":"2021-10-01","current":-14.394995,"twenty":-32.77883,"median":-24.013514,"eighty":-18.637897,"marketCap":472808544},{"date":"2021-10-08","current":-13.103541,"twenty":-32.344818,"median":-22.959864,"eighty":-18.095512,"marketCap":430390272},{"date":"2021-10-15","current":-14.410745,"twenty":-31.986036,"median":-21.866106,"eighty":-17.513386,"marketCap":473325840},{"date":"2021-10-22","current":-14.190252,"twenty":-31.934562,"median":-21.542932,"eighty":-16.458173,"marketCap":466083696},{"date":"2021-10-29","current":-13.41853,"twenty":-31.706074,"median":-21.40929,"eighty":-15.371461,"marketCap":440736192},{"date":"2021-11-05","current":-14.914727,"twenty":-31.586644,"median":-21.186556,"eighty":-15.157269,"marketCap":489879312},{"date":"2021-11-12","current":-3.671231,"twenty":-31.462605,"median":-20.919274,"eighty":-14.943076,"marketCap":428840912},{"date":"2021-11-19","current":-3.038568,"twenty":-31.405239,"median":-20.812361,"eighty":-14.741483,"marketCap":354938716},{"date":"2021-11-26","current":-2.744513,"twenty":-31.300997,"median":-20.402528,"eighty":-14.53674,"marketCap":320589808},{"date":"2021-12-03","current":-2.30343,"twenty":-31.246626,"median":-20.10623,"eighty":-14.410745,"marketCap":269066446},{"date":"2021-12-10","current":-2.36135,"twenty":-31.005605,"median":-19.708035,"eighty":-14.269,"marketCap":275832140},{"date":"2021-12-17","current":-2.241055,"twenty":-30.381057,"median":-19.542356,"eighty":-14.143004,"marketCap":261780314},{"date":"2021-12-23","current":-2.223233,"twenty":-30.316041,"median":-19.293073,"eighty":-13.742968,"marketCap":259698562},{"date":"2021-12-31","current":-1.857892,"twenty":-30.105321,"median":-19.009584,"eighty":-13.387031,"marketCap":217022646},{"date":"2022-01-07","current":-1.71532,"twenty":-30.045341,"median":-18.896839,"eighty":-13.031093,"marketCap":200368630},{"date":"2022-01-14","current":-1.434632,"twenty":-28.912363,"median":-18.82059,"eighty":-3.425295,"marketCap":167581036},{"date":"2022-01-21","current":-1.189586,"twenty":-28.520385,"median":-18.663096,"eighty":-2.991341,"marketCap":138956946},{"date":"2022-01-28","current":-1.127211,"twenty":-28.335341,"median":-18.328147,"eighty":-2.757879,"marketCap":131670814},{"date":"2022-02-04","current":-1.069291,"twenty":-28.244568,"median":-18.048867,"eighty":-2.58501,"marketCap":124905120},{"date":"2022-02-11","current":-1.015826,"twenty":-28.078924,"median":-17.710641,"eighty":-2.393429,"marketCap":118659864},{"date":"2022-02-18","current":-0.984638,"twenty":-27.856384,"median":-17.11965,"eighty":-2.241055,"marketCap":115016798},{"date":"2022-02-25","current":-0.993549,"twenty":-27.75309,"median":-16.710164,"eighty":-2.200065,"marketCap":116057674},{"date":"2022-03-04","current":-0.850977,"twenty":-27.614098,"median":-15.749448,"eighty":-2.151056,"marketCap":99403658},{"date":"2022-03-11","current":-0.85837,"twenty":-27.309643,"median":-15.418709,"eighty":-1.947891,"marketCap":100267205},{"date":"2022-03-18","current":-0.907292,"twenty":-26.980094,"median":-15.253341,"eighty":-1.74829,"marketCap":105981916},{"date":"2022-03-25","current":-0.92953,"twenty":-26.787741,"median":-15.11947,"eighty":-1.632451,"marketCap":108579512},{"date":"2022-04-01","current":-0.889502,"twenty":-26.66879,"median":-14.961976,"eighty":-1.329484,"marketCap":103903840},{"date":"2022-04-08","current":-0.778315,"twenty":-26.504298,"median":-14.772982,"eighty":-1.217209,"marketCap":90915860},{"date":"2022-04-14","current":-0.729392,"twenty":-26.367676,"median":-14.741483,"eighty":-1.191368,"marketCap":85201148},{"date":"2022-04-22","current":-0.581341,"twenty":-26.136985,"median":-14.583989,"eighty":-1.092459,"marketCap":71240380},{"date":"2022-04-29","current":-0.492264,"twenty":-25.851203,"median":-14.489492,"eighty":-1.070182,"marketCap":60324516},{"date":"2022-05-06","current":-0.435255,"twenty":-25.737579,"median":-14.40287,"eighty":-1.023845,"marketCap":53338362},{"date":"2022-05-13","current":-0.374027,"twenty":-25.613626,"median":-14.363496,"eighty":-1.003351,"marketCap":45835141},{"date":"2022-05-20","current":-0.336474,"twenty":-25.324668,"median":-14.190252,"eighty":-0.973054,"marketCap":41233242},{"date":"2022-05-27","current":-0.315424,"twenty":-25.040182,"median":-14.143004,"eighty":-0.944652,"marketCap":38653651},{"date":"2022-06-03","current":-0.285326,"twenty":-24.999779,"median":-13.954011,"eighty":-0.925082,"marketCap":34965238},{"date":"2022-06-10","current":-0.295218,"twenty":-24.945654,"median":-13.631147,"eighty":-0.907292,"marketCap":36177474},{"date":"2022-06-17","current":-0.229723,"twenty":-24.790712,"median":-13.387031,"eighty":-0.898397,"marketCap":28151440},{"date":"2022-06-24","current":-0.269573,"twenty":-24.652986,"median":-13.371281,"eighty":-0.866375,"marketCap":33034854},{"date":"2022-07-01","current":-0.27255,"twenty":-24.610668,"median":-12.922422,"eighty":-0.837611,"marketCap":30906602},{"date":"2022-07-08","current":-0.361389,"twenty":-24.58853,"median":-3.657865,"eighty":-0.813005,"marketCap":40980844},{"date":"2022-07-15","current":-0.294291,"twenty":-23.901199,"median":-3.368266,"eighty":-0.76942,"marketCap":33372004},{"date":"2022-07-22","current":-0.270675,"twenty":-23.193912,"median":-2.989559,"eighty":-0.706884,"marketCap":30693968},{"date":"2022-07-29","current":-0.247008,"twenty":-22.984675,"median":-2.922728,"eighty":-0.592592,"marketCap":28010185},{"date":"2022-08-05","current":-0.267786,"twenty":-22.74049,"median":-2.697731,"eighty":-0.525082,"marketCap":30366397},{"date":"2022-08-12","current":-0.314274,"twenty":-22.158822,"median":-2.615307,"eighty":-0.485701,"marketCap":33536542},{"date":"2022-08-19","current":-0.260857,"twenty":-21.865619,"median":-2.45714,"eighty":-0.412611,"marketCap":27836330},{"date":"2022-08-26","current":-0.220505,"twenty":-21.788831,"median":-2.36135,"eighty":-0.368972,"marketCap":23530288},{"date":"2022-09-02","current":-0.209424,"twenty":-21.621334,"median":-2.247738,"eighty":-0.348362,"marketCap":22347891},{"date":"2022-09-09","current":-0.190516,"twenty":-21.507294,"median":-2.232144,"eighty":-0.335714,"marketCap":20330168},{"date":"2022-09-16","current":-0.17238,"twenty":-21.439583,"median":-2.18759,"eighty":-0.325246,"marketCap":18394802},{"date":"2022-09-23","current":-0.126956,"twenty":-21.411072,"median":-2.163086,"eighty":-0.314749,"marketCap":13547563},{"date":"2022-09-30","current":-0.136107,"twenty":-21.371871,"median":-2.143037,"eighty":-0.307812,"marketCap":14524070},{"date":"2022-10-07","current":-0.127397,"twenty":-21.272086,"median":-1.958139,"eighty":-0.305326,"marketCap":13594623},{"date":"2022-10-14","current":-0.113064,"twenty":-21.165173,"median":-1.857892,"eighty":-0.296303,"marketCap":12065155},{"date":"2022-10-21","current":-0.100605,"twenty":-21.047569,"median":-1.717548,"eighty":-0.292372,"marketCap":10735693},{"date":"2022-10-28","current":-0.097022,"twenty":-20.919274,"median":-1.661856,"eighty":-0.287257,"marketCap":10353326},{"date":"2022-11-04","current":-0.080484,"twenty":-20.912146,"median":-1.470275,"eighty":-0.277075,"marketCap":8588555},{"date":"2022-11-11","current":-0.089304,"twenty":-20.865817,"median":-1.30097,"eighty":-0.268501,"marketCap":9529766},{"date":"2022-11-18","current":-0.334689,"twenty":-20.676938,"median":-1.229684,"eighty":-0.270014,"marketCap":9385362},{"date":"2022-11-25","current":-0.346231,"twenty":-20.459549,"median":-1.211863,"eighty":-0.27105,"marketCap":9708996},{"date":"2022-12-02","current":-0.346231,"twenty":-20.384709,"median":-1.189586,"eighty":-0.27293,"marketCap":9708996},{"date":"2022-12-09","current":-1.003766,"twenty":-20.299179,"median":-1.104934,"eighty":-0.275762,"marketCap":28147614},{"date":"2022-12-16","current":-0.687461,"twenty":-20.187787,"median":-1.087112,"eighty":-0.281392,"marketCap":19277783},{"date":"2022-12-23","current":-0.627125,"twenty":-19.928386,"median":-1.071519,"eighty":-0.283392,"marketCap":17585850},{"date":"2022-12-30","current":-0.58873,"twenty":-19.76073,"median":-1.058152,"eighty":-0.285326,"marketCap":16509165},{"date":"2023-01-06","current":-0.62164,"twenty":-19.718574,"median":-1.029192,"eighty":-0.286526,"marketCap":17432038},{"date":"2023-01-13","current":-0.850185,"twenty":-19.707683,"median":-1.011371,"eighty":-0.287688,"marketCap":23840875},{"date":"2023-01-20","current":-0.895893,"twenty":-19.644625,"median":-1.003766,"eighty":-0.287904,"marketCap":25122643},{"date":"2023-01-27","current":-0.884923,"twenty":-19.530298,"median":-0.989094,"eighty":-0.289577,"marketCap":24815018},{"date":"2023-02-03","current":-0.870296,"twenty":-19.378121,"median":-0.971272,"eighty":-0.290932,"marketCap":24404853},{"date":"2023-02-10","current":-0.745054,"twenty":-19.289924,"median":-0.957065,"eighty":-0.293011,"marketCap":20892810},{"date":"2023-02-17","current":-0.694793,"twenty":-19.163928,"median":-0.92953,"eighty":-0.294847,"marketCap":19483378},{"date":"2023-02-24","current":-0.667349,"twenty":-19.056832,"median":-0.925082,"eighty":-0.295274,"marketCap":18713805},{"date":"2023-03-03","current":-0.674663,"twenty":-18.996984,"median":-0.917925,"eighty":-0.295584,"marketCap":18918888},{"date":"2023-03-10","current":-0.642538,"twenty":-18.956278,"median":-0.91174,"eighty":-0.296303,"marketCap":18018062},{"date":"2023-03-17","current":-0.638095,"twenty":-18.902185,"median":-0.908794,"eighty":-0.297808,"marketCap":17893474},{"date":"2023-03-24","current":-0.688365,"twenty":-18.856603,"median":-0.907778,"eighty":-0.300802,"marketCap":16919331},{"date":"2023-03-31","current":-0.709225,"twenty":-18.83004,"median":-0.905069,"eighty":-0.30391,"marketCap":17432038},{"date":"2023-04-06","current":-0.705053,"twenty":-18.792241,"median":-0.899191,"eighty":-0.305155,"marketCap":17329496},{"date":"2023-04-14","current":-0.682107,"twenty":-18.675695,"median":-0.895893,"eighty":-0.305841,"marketCap":16765518},{"date":"2023-04-21","current":-0.670748,"twenty":-18.656796,"median":-0.888836,"eighty":-0.305955,"marketCap":16486310},{"date":"2023-04-28","current":-0.615289,"twenty":-18.579515,"median":-0.884923,"eighty":-0.306454,"marketCap":15123199},{"date":"2023-05-05","current":-0.681327,"twenty":-18.35397,"median":-0.875781,"eighty":-0.30726,"marketCap":16746347},{"date":"2023-05-12","current":-0.599864,"twenty":-18.284505,"median":-0.868468,"eighty":-0.310367,"marketCap":14744066},{"date":"2023-05-19","current":-0.69109,"twenty":-18.235446,"median":-0.861071,"eighty":-0.314018,"marketCap":14250274},{"date":"2023-05-26","current":-0.488159,"twenty":-18.045717,"median":-0.853841,"eighty":-0.314279,"marketCap":10065837},{"date":"2023-06-02","current":-0.55461,"twenty":-18.033118,"median":-0.850185,"eighty":-0.314299,"marketCap":11436056},{"date":"2023-06-09","current":-0.527518,"twenty":-17.907896,"median":-0.837611,"eighty":-0.315424,"marketCap":10877428},{"date":"2023-06-16","current":-0.569945,"twenty":-17.513386,"median":-0.832175,"eighty":-0.317417,"marketCap":11752260},{"date":"2023-06-23","current":-0.644063,"twenty":-17.513386,"median":-0.831793,"eighty":-0.320326,"marketCap":13280581},{"date":"2023-06-30","current":-0.572526,"twenty":-17.355892,"median":-0.82774,"eighty":-0.322914,"marketCap":11805488},{"date":"2023-07-07","current":-0.590391,"twenty":-17.066102,"median":-0.803551,"eighty":-0.324567,"marketCap":12173866},{"date":"2023-07-14","current":-0.66704,"twenty":-16.82356,"median":-0.782762,"eighty":-0.327297,"marketCap":13754360},{"date":"2023-07-21","current":-0.744904,"twenty":-16.647166,"median":-0.776828,"eighty":-0.327511,"marketCap":15359929},{"date":"2023-07-28","current":-0.711057,"twenty":-16.278629,"median":-0.757656,"eighty":-0.328261,"marketCap":14661997},{"date":"2023-08-04","current":-0.750414,"twenty":-15.787247,"median":-0.753246,"eighty":-0.329188,"marketCap":15473546},{"date":"2023-08-11","current":-0.703186,"twenty":-15.661251,"median":-0.750388,"eighty":-0.332171,"marketCap":14499687},{"date":"2023-08-18","current":-0.600041,"twenty":-15.532105,"median":-0.744379,"eighty":-0.334793,"marketCap":13038897},{"date":"2023-08-25","current":-0.560205,"twenty":-15.39981,"median":-0.742386,"eighty":-0.335461,"marketCap":12173244},{"date":"2023-09-01","current":-0.607511,"twenty":-15.324213,"median":-0.734672,"eighty":-0.336537,"marketCap":13201207},{"date":"2023-09-08","current":-0.580123,"twenty":-15.324213,"median":-0.729424,"eighty":-0.336725,"marketCap":12606071},{"date":"2023-09-15","current":-0.522858,"twenty":-15.239166,"median":-0.7268,"eighty":-0.337894,"marketCap":11361695},{"date":"2023-09-21","current":-0.512898,"twenty":-15.176168,"median":-0.724917,"eighty":-0.339521,"marketCap":11145281},{"date":"2023-09-29","current":-0.562694,"twenty":-15.144669,"median":-0.721172,"eighty":-0.343293,"marketCap":12227348},{"date":"2023-10-06","current":-0.525347,"twenty":-15.103721,"median":-0.714743,"eighty":-0.344552,"marketCap":11415798},{"date":"2023-10-13","current":-0.502939,"twenty":-15.031273,"median":-0.713021,"eighty":-0.346231,"marketCap":10928868},{"date":"2023-10-19","current":-0.49796,"twenty":-15.002924,"median":-0.710141,"eighty":-0.346231,"marketCap":10820662},{"date":"2023-10-23","current":-0.43696,"twenty":-14.993474,"median":-0.709225,"eighty":-0.346231,"marketCap":9495130},{"date":"2023-11-01","current":-0.351037,"twenty":-14.955676,"median":-0.709225,"eighty":-0.345391,"marketCap":7628025},{"date":"2023-11-10","current":-0.273878,"twenty":-14.921027,"median":-0.709037,"eighty":-0.340114,"marketCap":5951364},{"date":"2023-11-17","current":-0.31245,"twenty":-14.82968,"median":-0.707356,"eighty":-0.335,"marketCap":6250555},{"date":"2023-11-24","current":-0.265215,"twenty":-14.760382,"median":-0.706616,"eighty":-0.328346,"marketCap":5305370},{"date":"2023-12-01","current":-0.243416,"twenty":-14.741483,"median":-0.705095,"eighty":-0.324798,"marketCap":4869303},{"date":"2023-12-08","current":-0.392171,"twenty":-14.703684,"median":-0.703916,"eighty":-0.324798,"marketCap":7844979},{"date":"2023-12-15","current":-0.489537,"twenty":-14.640686,"median":-0.702088,"eighty":-0.326602,"marketCap":9792699},{"date":"2023-12-22","current":-0.462491,"twenty":-14.593438,"median":-0.69638,"eighty":-0.32727,"marketCap":9251666},{"date":"2023-12-29","current":-0.497624,"twenty":-14.53674,"median":-0.694793,"eighty":-0.327285,"marketCap":9954468},{"date":"2024-01-05","current":-0.530106,"twenty":-14.508391,"median":-0.69077,"eighty":-0.327321,"marketCap":10604248},{"date":"2024-01-12","current":-0.473309,"twenty":-14.489492,"median":-0.689289,"eighty":-0.327844,"marketCap":9468079},{"date":"2024-01-19","current":-0.375943,"twenty":-14.464293,"median":-0.687461,"eighty":-0.328346,"marketCap":7520360},{"date":"2024-01-26","current":-0.476041,"twenty":-14.420194,"median":-0.685956,"eighty":-0.329362,"marketCap":9522723},{"date":"2024-02-02","current":-0.462491,"twenty":-14.404445,"median":-0.684214,"eighty":-0.33092,"marketCap":9251666},{"date":"2024-02-09","current":-0.43274,"twenty":-14.394995,"median":-0.681717,"eighty":-0.332801,"marketCap":8656529},{"date":"2024-02-16","current":-0.430035,"twenty":-14.382395,"median":-0.679793,"eighty":-0.334897,"marketCap":8602426},{"date":"2024-02-23","current":-0.411103,"twenty":-14.344597,"median":-0.675577,"eighty":-0.335461,"marketCap":8223703},{"date":"2024-03-01","current":-0.421921,"twenty":-14.25325,"median":-0.673579,"eighty":-0.336537,"marketCap":8440116},{"date":"2024-03-08","current":-0.538193,"twenty":-14.190252,"median":-0.670748,"eighty":-0.337157,"marketCap":10766017},{"date":"2024-03-15","current":-0.593665,"twenty":-14.183952,"median":-0.669178,"eighty":-0.339125,"marketCap":11875676},{"date":"2024-03-22","current":-0.581708,"twenty":-14.155604,"median":-0.667349,"eighty":-0.341102,"marketCap":12604448},{"date":"2024-03-28","current":-0.559311,"twenty":-14.143004,"median":-0.66704,"eighty":-0.341102,"marketCap":12119141},{"date":"2024-04-05","current":-0.574292,"twenty":-14.095756,"median":-0.664588,"eighty":-0.343083,"marketCap":12443761},{"date":"2024-04-12","current":-0.564304,"twenty":-13.954011,"median":-0.659122,"eighty":-0.344132,"marketCap":12227348},{"date":"2024-04-19","current":-0.536838,"twenty":-13.765017,"median":-0.655936,"eighty":-0.346231,"marketCap":11632211},{"date":"2024-04-26","current":-0.433391,"twenty":-13.654771,"median":-0.651731,"eighty":-0.346231,"marketCap":9390711},{"date":"2024-05-03","current":-0.426974,"twenty":-13.607523,"median":-0.643822,"eighty":-0.346642,"marketCap":9251666},{"date":"2024-05-10","current":-0.539335,"twenty":-13.41853,"median":-0.641752,"eighty":-0.349508,"marketCap":11686314},{"date":"2024-05-17","current":-0.479627,"twenty":-13.387031,"median":-0.635906,"eighty":-0.351037,"marketCap":10982971},{"date":"2024-05-24","current":-0.470176,"twenty":-13.387031,"median":-0.634777,"eighty":-0.351664,"marketCap":10766558},{"date":"2024-05-31","current":-0.432373,"twenty":-13.374431,"median":-0.63384,"eighty":-0.351664,"marketCap":9900905},{"date":"2024-06-07","current":-0.481989,"twenty":-13.220087,"median":-0.632737,"eighty":-0.352354,"marketCap":11037075},{"date":"2024-06-14","current":-0.467813,"twenty":-13.13504,"median":-0.628835,"eighty":-0.352526,"marketCap":10712455},{"date":"2024-06-21","current":-0.464624,"twenty":-12.958646,"median":-0.624821,"eighty":-0.35433,"marketCap":10639415},{"date":"2024-06-28","current":-0.413471,"twenty":-12.813751,"median":-0.623177,"eighty":-0.356135,"marketCap":9468079},{"date":"2024-07-05","current":-0.415834,"twenty":-7.29926,"median":-0.621325,"eighty":-0.358737,"marketCap":9522182},{"date":"2024-07-12","current":-0.458362,"twenty":-3.655192,"median":-0.61996,"eighty":-0.360781,"marketCap":10496042},{"date":"2024-07-15","current":-0.484352,"twenty":-3.649845,"median":-0.617625,"eighty":-0.361085,"marketCap":11091178},{"date":"2024-08-02","current":-0.406407,"twenty":-3.644499,"median":-0.615289,"eighty":-0.361389,"marketCap":9306310},{"date":"2024-08-09","current":-0.434759,"twenty":-3.439552,"median":-0.612499,"eighty":-0.367214,"marketCap":9955550},{"date":"2024-08-16","current":-0.391318,"twenty":-3.368266,"median":-0.609386,"eighty":-0.373509,"marketCap":9360317},{"date":"2024-08-23","current":-0.420723,"twenty":-3.038568,"median":-0.605511,"eighty":-0.374027,"marketCap":10063693},{"date":"2024-08-30","current":-0.413937,"twenty":-2.998469,"median":-0.605021,"eighty":-0.37459,"marketCap":9901376},{"date":"2024-09-06","current":-0.380008,"twenty":-2.984212,"median":-0.602531,"eighty":-0.375672,"marketCap":9089787},{"date":"2024-09-13","current":-0.346079,"twenty":-2.962826,"median":-0.599952,"eighty":-0.366049,"marketCap":8278199},{"date":"2024-09-20","current":-0.285006,"twenty":-2.929857,"median":-0.598858,"eighty":-0.352526,"marketCap":6817340},{"date":"2024-09-27","current":-0.287268,"twenty":-2.797978,"median":-0.594949,"eighty":-0.35095,"marketCap":6871446},{"date":"2024-10-04","current":-0.214863,"twenty":-2.748968,"median":-0.593665,"eighty":-0.348935,"marketCap":5139517},{"date":"2024-10-11","current":-0.242029,"twenty":-2.669663,"median":-0.591669,"eighty":-0.34569,"marketCap":5789329},{"date":"2024-10-18","current":-0.242029,"twenty":-2.647385,"median":-0.587835,"eighty":-0.341464,"marketCap":5789329},{"date":"2024-10-25","current":-0.214908,"twenty":-2.621544,"median":-0.585317,"eighty":-0.338262,"marketCap":5140599},{"date":"2024-10-31","current":-0.248815,"twenty":-2.569862,"median":-0.582161,"eighty":-0.335,"marketCap":5951646},{"date":"2024-11-08","current":-0.244291,"twenty":-2.496793,"median":-0.581341,"eighty":-0.32843,"marketCap":5843435},{"date":"2024-11-15","current":-1.08538,"twenty":-2.454913,"median":-0.581379,"eighty":-0.327844,"marketCap":48769398},{"date":"2024-11-22","current":-0.608498,"twenty":-2.42729,"median":-0.582613,"eighty":-0.32843,"marketCap":27341622},{"date":"2024-11-29","current":-0.485929,"twenty":-2.393429,"median":-0.582613,"eighty":-0.329362,"marketCap":21834253},{"date":"2024-12-06","current":-0.362332,"twenty":-2.344648,"median":-0.581379,"eighty":-0.33092,"marketCap":16280646},{"date":"2024-12-13","current":-0.331346,"twenty":-2.313128,"median":-0.577612,"eighty":-0.331424,"marketCap":14888391},{"date":"2024-12-20","current":-0.282982,"twenty":-2.283826,"median":-0.574292,"eighty":-0.328346,"marketCap":12715241},{"date":"2024-12-27","current":-0.323686,"twenty":-2.251748,"median":-0.574198,"eighty":-0.327265,"marketCap":14544181},{"date":"2025-01-03","current":-0.421901,"twenty":-2.241055,"median":-0.57259,"eighty":-0.326164,"marketCap":18957269},{"date":"2025-01-10","current":-0.369649,"twenty":-2.241055,"median":-0.571345,"eighty":-0.327041,"marketCap":16609444},{"date":"2025-01-17","current":-0.51337,"twenty":-2.226797,"median":-0.569945,"eighty":-0.32728,"marketCap":23067246},{"date":"2025-01-24","current":-0.66315,"twenty":-2.22056,"median":-0.569945,"eighty":-0.327321,"marketCap":29797333},{"date":"2025-01-31","current":-0.418928,"twenty":-2.200065,"median":-0.568486,"eighty":-0.327844,"marketCap":18823694},{"date":"2025-02-07","current":-0.388743,"twenty":-2.176897,"median":-0.56679,"eighty":-0.32843,"marketCap":17467402},{"date":"2025-02-14","current":-0.32906,"twenty":-2.169769,"median":-0.565812,"eighty":-0.327844,"marketCap":14785642},{"date":"2025-02-21","current":-0.387486,"twenty":-2.164423,"median":-0.564304,"eighty":-0.328346,"marketCap":17410890},{"date":"2025-02-28","current":-0.326773,"twenty":-2.152839,"median":-0.562694,"eighty":-0.328346,"marketCap":14682892},{"date":"2025-03-07","current":-0.33672,"twenty":-2.14571,"median":-0.559758,"eighty":-0.327309,"marketCap":15129852},{"date":"2025-03-14","current":-0.294137,"twenty":-2.093137,"median":-0.557899,"eighty":-0.32643,"marketCap":13100551},{"date":"2025-03-21","current":-0.317418,"twenty":-2.014722,"median":-0.555167,"eighty":-0.324255,"marketCap":14137477},{"date":"2025-03-28","current":-0.265453,"twenty":-1.968386,"median":-0.554317,"eighty":-0.319136,"marketCap":11823027},{"date":"2025-04-04","current":-0.212316,"twenty":-1.894427,"median":-0.551298,"eighty":-0.318025,"marketCap":9456332},{"date":"2025-04-11","current":-0.218415,"twenty":-1.868585,"median":-0.549323,"eighty":-0.314749,"marketCap":9728005},{"date":"2025-04-17","current":-0.2156,"twenty":-1.844526,"median":-0.544579,"eighty":-0.312751,"marketCap":9602617},{"date":"2025-04-25","current":-0.240351,"twenty":-1.776805,"median":-0.542304,"eighty":-0.310623,"marketCap":10704985},{"date":"2025-05-02","current":-0.230263,"twenty":-1.718885,"median":-0.540286,"eighty":-0.30886,"marketCap":10255679},{"date":"2025-05-09","current":-0.226575,"twenty":-1.705518,"median":-0.539305,"eighty":-0.306274,"marketCap":10443761},{"date":"2025-05-16","current":-0.316595,"twenty":-1.66542,"median":-0.538193,"eighty":-0.305841,"marketCap":14593120},{"date":"2025-05-23","current":-0.309018,"twenty":-1.652054,"median":-0.536838,"eighty":-0.305841,"marketCap":14243883},{"date":"2025-05-30","current":-0.30983,"twenty":-1.612847,"median":-0.536779,"eighty":-0.305846,"marketCap":14281301},{"date":"2025-06-06","current":-0.24624,"twenty":-1.505918,"median":-0.535805,"eighty":-0.304984,"marketCap":11350204},{"date":"2025-06-13","current":-0.213769,"twenty":-1.434632,"median":-0.534833,"eighty":-0.299675,"marketCap":9853478},{"date":"2025-06-20","current":-0.420011,"twenty":-1.384731,"median":-0.534341,"eighty":-0.299606,"marketCap":19359969},{"date":"2025-06-27","current":-0.30343,"twenty":-1.315227,"median":-0.533,"eighty":-0.300124,"marketCap":13986283},{"date":"2025-07-03","current":-0.3194,"twenty":-1.271565,"median":-0.530327,"eighty":-0.299282,"marketCap":14722404},{"date":"2025-07-11","current":-0.316206,"twenty":-1.241268,"median":-0.528444,"eighty":-0.299282,"marketCap":14575179},{"date":"2025-07-18","current":-0.325788,"twenty":-1.228793,"median":-0.526496,"eighty":-0.299538,"marketCap":15016852},{"date":"2025-07-25","current":-0.33537,"twenty":-1.217209,"median":-0.525082,"eighty":-0.300012,"marketCap":15458524},{"date":"2025-08-01","current":-0.276281,"twenty":-1.211863,"median":-0.52394,"eighty":-0.299282,"marketCap":12734879},{"date":"2025-08-08","current":-0.263089,"twenty":-1.203843,"median":-0.522858,"eighty":-0.296323,"marketCap":12126844},{"date":"2025-08-15","current":-0.272862,"twenty":-1.19315,"median":-0.519153,"eighty":-0.295411,"marketCap":11925147},{"date":"2025-08-22","current":-0.266789,"twenty":-1.152161,"median":-0.512898,"eighty":-0.29489,"marketCap":11659751},{"date":"2025-08-29","current":-0.242216,"twenty":-1.113845,"median":-0.511174,"eighty":-0.293827,"marketCap":10585826},{"date":"2025-09-05","current":-0.214133,"twenty":-1.104934,"median":-0.511161,"eighty":-0.291556,"marketCap":9358484},{"date":"2025-09-12","current":-0.242216,"twenty":-1.098696,"median":-0.508537,"eighty":-0.289375,"marketCap":10585826},{"date":"2025-09-19","current":-0.222909,"twenty":-1.088449,"median":-0.505792,"eighty":-0.287316,"marketCap":9742029},{"date":"2025-09-26","current":-0.196581,"twenty":-1.086419,"median":-0.504916,"eighty":-0.285541,"marketCap":8591395},{"date":"2025-10-03","current":-0.213256,"twenty":-1.084291,"median":-0.50308,"eighty":-0.284181,"marketCap":9320130},{"date":"2025-10-10","current":-0.235196,"twenty":-1.079499,"median":-0.501915,"eighty":-0.281642,"marketCap":10278991},{"date":"2025-10-17","current":-0.219399,"twenty":-1.074355,"median":-0.49796,"eighty":-0.274488,"marketCap":9588611},{"date":"2025-10-24","current":-0.205357,"twenty":-1.071964,"median":-0.496913,"eighty":-0.272675,"marketCap":8974940},{"date":"2025-10-31","current":-0.312424,"twenty":-1.067509,"median":-0.494391,"eighty":-0.272055,"marketCap":13654182},{"date":"2025-11-07","current":-0.296627,"twenty":-1.059489,"median":-0.491955,"eighty":-0.272253,"marketCap":12963802},{"date":"2025-11-14","current":-0.671869,"twenty":-1.046123,"median":-0.494391,"eighty":-0.272675,"marketCap":12322755},{"date":"2025-11-21","current":-0.547766,"twenty":-1.030974,"median":-0.496913,"eighty":-0.272984,"marketCap":10046577},{"date":"2025-11-28","current":-0.577722,"twenty":-1.01939,"median":-0.497792,"eighty":-0.273309,"marketCap":10596000},{"date":"2025-12-05","current":-0.560604,"twenty":-1.014935,"median":-0.498277,"eighty":-0.273992,"marketCap":10282044},{"date":"2025-12-12","current":-0.633355,"twenty":-1.01048,"median":-0.503,"eighty":-0.274468,"marketCap":11616355},{"date":"2025-12-19","current":-0.539207,"twenty":-1.006285,"median":-0.503194,"eighty":-0.274828,"marketCap":9889600},{"date":"2025-12-26","current":-0.543487,"twenty":-1.003766,"median":-0.505429,"eighty":-0.275958,"marketCap":9968089},{"date":"2026-01-02","current":-0.513531,"twenty":-1.002721,"median":-0.505429,"eighty":-0.276216,"marketCap":9418666},{"date":"2026-01-09","current":-0.59484,"twenty":-0.995331,"median":-0.505779,"eighty":-0.280067,"marketCap":10909955},{"date":"2026-01-16","current":-0.504972,"twenty":-0.98642,"median":-0.505846,"eighty":-0.282271,"marketCap":9261689},{"date":"2026-01-23","current":-0.530648,"twenty":-0.981965,"median":-0.508469,"eighty":-0.282779,"marketCap":9732622},{"date":"2026-01-30","current":-0.513531,"twenty":-0.974836,"median":-0.508537,"eighty":-0.282952,"marketCap":9418666},{"date":"2026-02-06","current":-0.291001,"twenty":-0.970244,"median":-0.508469,"eighty":-0.283495,"marketCap":5337244},{"date":"2026-02-13","current":-0.537298,"twenty":-0.96524,"median":-0.505819,"eighty":-0.282779,"marketCap":9854581},{"date":"2026-02-20","current":-0.544479,"twenty":-0.9593,"median":-0.505819,"eighty":-0.282938,"marketCap":9986281}],"updateTime":1771780415019},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ERNA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612267745","title":"Ernexa Therapeutics CEO Sanjeev Luther to Join Virtual Investor Closing Bell Series Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2612267745","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612267745?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:05","pubTimestamp":1771596311,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL2nmjv9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014005.SGD","SG9999014013.SGD","BK4112","IE00BGHQF748.EUR","SG9999014021.USD","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","LU2210150020.SGD","BK4139","LU2095319765.USD","IE00B3QW5Z07.USD","ERNA","SG9999014039.USD","BK4585","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2612924484","title":"10% Owner Charles Cherington Reports Acquisition of Ernexa Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612924484","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612924484?lang=en_us&edition=fundamental","pubTime":"2026-02-18 10:15","pubTimestamp":1771380913,"startTime":"0","endTime":"0","summary":"Charles Cherington, a 10% owner, reported the acquisition of common shares of Ernexa Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL2YFxhK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"10% Owner Charles Cherington Reports Acquisition of Ernexa Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2610642259","title":"Ernexa Therapeutics Announces Issuance of Warrants in $10.5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2610642259","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610642259?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:11","pubTimestamp":1770847868,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics Inc. has announced the pricing of a public offering consisting of 21,000,000 shares of its common stock  and warrants to purchase up to 21,000,000 shares of common stock. The combined public offering price is $0.50 per share and accompanying warrant. The warrants have an exercise price of $0.68 per share, are exercisable upon issuance, and will expire on the earlier of five years from the issuance date or 180 days after the public release of clinical trial data from the first cohort of the Phase 1 study of ERNA-101. The gross proceeds from the offering are expected to be approximately $10.5 million, with potential additional proceeds of $14.3 million if all warrants are exercised. Ernexa intends to use the net proceeds to advance its development programs, for working capital, and for general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL9rps2n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2609594170","title":"Ernexa Therapeutics prices 21M shares at 50c in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2609594170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609594170?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:30","pubTimestamp":1770388230,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics (ERNA) announced the pricing of a best-efforts registered public offering of 21,000,000 shares of its common stock and warrants...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-prices-21m-shares-at-50c-in-public-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-prices-21m-shares-at-50c-in-public-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539","ERNA"],"gpt_icon":0},{"id":"2609594329","title":"Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2609594329","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609594329?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:25","pubTimestamp":1770387900,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Feb.  06, 2026  (GLOBE NEWSWIRE) -- Ernexa Therapeutics Inc. (Nasdaq: ERNA) (“Ernexa” or the “Company”), an industry innovator developing novel cell therapies for the treatment of ad","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/06/3233873/0/en/Ernexa-Therapeutics-Announces-Pricing-of-10-5-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2608874147","title":"Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2608874147","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608874147?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:45","pubTimestamp":1770126300,"startTime":"0","endTime":"0","summary":"Access the “What This Means” segmenthere CAMBRIDGE, Mass., Feb.  03, 2026  (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatme","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/03/3231107/0/en/Ernexa-Therapeutics-Participates-in-Virtual-Investor-What-This-Means-Segment-Highlighting-Recent-Successful-Pre-IND-Meeting-with-U-S-FDA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IND","ERNA","LENZ","BK4539"],"gpt_icon":0},{"id":"2606787674","title":"Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2606787674","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606787674?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:45","pubTimestamp":1769521500,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Jan.  27, 2026  (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune dise","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/27/3226519/0/en/Ernexa-Therapeutics-Selected-as-One-of-Only-Ten-Global-Companies-for-Prestigious-JETRO-Japan-Entry-Acceleration-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2601081806","title":"BRIEF-Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2601081806","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601081806?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:11","pubTimestamp":1767708695,"startTime":"0","endTime":"0","summary":"BRIEF-Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting Jan 6 (Reuters) - Ernexa Therapeutics Inc ERNA.O:ERNEXA THERAPEUTICS ANNOUNCES SUCCESSFUL PRE-IND FDA MEETING AND CONTINUES PROGRESS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA60J3XN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2601818311","title":"Eterna Therapeutics Expects to Begin First-in-Human Ovarian Cancer Trial in H2","url":"https://stock-news.laohu8.com/highlight/detail?id=2601818311","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601818311?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:54","pubTimestamp":1767707652,"startTime":"0","endTime":"0","summary":"Eterna Therapeutics  said Tuesday it is on track to initiate its first-in-human ovarian cancer trial in H2 2026.The company said it recently concluded a pre-investigational new drug application meeting with the US Food and Drug Administration, with feedback from the agency setting a pathway for submitting an investigational new drug application.Eterna said that following the meeting, it has boosted key operational activities, with tech transfer already underway.The company said it is currently progressing ERNA-101 therapy for ovarian cancer and ERNA-201 for autoimmune disease.Ernexa Therapeutics shares were down 4% in recent Tuesday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ERNA","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2601897227","title":"Ernexa Therapeutics Receives FDA Alignment to Advance Ovarian Cancer Cell Therapy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897227","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601897227?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:15","pubTimestamp":1767705309,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics Inc. has announced the successful completion of a Pre-Investigational New Drug Application  meeting with the U.S. Food and Drug Administration , achieving strong regulatory alignment for its development strategy. This feedback from the FDA sets a clear pathway for Ernexa to submit an IND and initiate its first-in-human trial for ovarian cancer in the second half of 2026. The company is advancing operational activities, including tech transfer, to accelerate clinical readiness for its lead therapy, ERNA-101, targeting ovarian cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 06, 2026, and is sol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL9ll6bb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","ERNA","SG9999014005.SGD","LU2210149790.SGD","BK4585","LU2095319765.USD","NDAQ","LU2210150020.SGD","SG9999014039.USD","BK4139","SG9999014013.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2601489747","title":"Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601489747","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601489747?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:15","pubTimestamp":1767705300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA60J3XN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2601189727","title":"Ernexa Therapeutics Inc - on Track to Initiate Fih Trial for Ovarian Cancer in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601189727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601189727?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:15","pubTimestamp":1767705300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA60J3XN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2589355483","title":"Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2589355483","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589355483?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:30","pubTimestamp":1765200600,"startTime":"0","endTime":"0","summary":"Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, underscoring the potential for broad oncology applications, including hematologic m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201527/0/en/Ernexa-Therapeutics-Presents-New-Preclinical-Data-at-American-Society-of-Hematology-ASH-Annual-Meeting-on-Lead-Cell-Therapy-Candidate-for-Treatment-of-Ovarian-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","ASH","BK4007","BK4139","LENZ","BK4539","BK4107","AFG","BK4117","LU2463526074.USD","ERNA"],"gpt_icon":0},{"id":"2588041871","title":"BRIEF-Ernexa Therapeutics Announces Oral Presentation At The 67Th American Society Of Hematology","url":"https://stock-news.laohu8.com/highlight/detail?id=2588041871","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588041871?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:33","pubTimestamp":1764768811,"startTime":"0","endTime":"0","summary":"BRIEF-Ernexa Therapeutics Announces Oral Presentation At The 67Th American Society Of Hematology Dec 3 (Reuters) - Ernexa Therapeutics Inc ERNA.O:ERNEXA THERAPEUTICS ANNOUNCES ORAL PRESENTATION AT THE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA9FGGWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2588504970","title":"Ernexa Therapeutics Announces Oral Presentation at the 67TH American Society of Hematology (Ash) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2588504970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588504970?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:30","pubTimestamp":1764768601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA9FGGWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2588056603","title":"Press Release: Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG","url":"https://stock-news.laohu8.com/highlight/detail?id=2588056603","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588056603?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:50","pubTimestamp":1764683400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec. 02, 2025  -- Ernexa Therapeutics , an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the appointment of Dr. Ira S. Winer, M.D., Ph.D., FACOG, to its Scientific and Medical Advisory Board.Dr. Winer is a nationally recognized gynecologic oncologist and translational scientist. His expertise in women's oncology, immunotherapy, and early-phase clinical development further strengthens Ernexa's capabilities as it advances its proprietary induced mesenchymal stem cells  platform and lead program, ERNA-101, toward key milestones, including first-in-human trials.\"We are delighted to welcome Dr. Winer to our Advisory Board,\" said Sanjeev Luther, President and CEO of Ernexa Therapeutics. \"His deep clinical and translational experience in women's oncology directly supports our mission to advance treatments for advanced cancer and autoimmune disease. As we move ERNA-101 forward in ovarian cancer ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","ERNA","BK4139","BK4007"],"gpt_icon":0},{"id":"2582667873","title":"Ernexa Therapeutics to Present at Oxford Global’s Cell 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582667873","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582667873?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:00","pubTimestamp":1762862400,"startTime":"0","endTime":"0","summary":"Sanjeev Luther, President and CEO to give an oral presentation and participate in a moderated panel discussionCAMBRIDGE, Mass., Nov.  11, 2025  (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/11/3185305/0/en/Ernexa-Therapeutics-to-Present-at-Oxford-Global-s-Cell-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","LENZ","BK4139","OXM","BK4007","BK4539","ERNA"],"gpt_icon":0},{"id":"2582010874","title":"Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2582010874","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582010874?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:35","pubTimestamp":1762781700,"startTime":"0","endTime":"0","summary":"The Company’s operating loss declined by 44% year-over-year, reflecting its continued laser focus on relentless execution and progress in operational excellence Continued progress with lead program, E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184603/0/en/Ernexa-Therapeutics-Reports-Strong-Quarterly-Performance-Highlighting-Operational-Execution-and-Progress-Toward-First-in-Human-Cell-Therapy-Trials.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ERNA","BK4139","LU2065732104.USD","PROC","BK4007","LENZ","PRGS","RA","BK4097"],"gpt_icon":0},{"id":"2581091906","title":"Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2581091906","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581091906?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:15","pubTimestamp":1762438500,"startTime":"0","endTime":"0","summary":"Access the “What This Means” segmenthere CAMBRIDGE, Mass., Nov.  06, 2025  (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3182716/0/en/Ernexa-Therapeutics-Showcases-Strategic-Partnership-with-Cellipont-Bioservices-to-Advance-Toward-First-in-Human-Trials-on-Virtual-Investor-What-This-Means-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA","BK4539","LENZ","BK4007"],"gpt_icon":0},{"id":"2579340907","title":"BRIEF-Cellipont Bioservices And Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership To Advance Erna-101 Toward Clinical Trials In Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2579340907","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579340907?lang=en_us&edition=fundamental","pubTime":"2025-10-29 22:23","pubTimestamp":1761747784,"startTime":"0","endTime":"0","summary":"BRIEF-Cellipont Bioservices And Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership To Advance Erna-101 Toward Clinical Trials In Ovarian CancerErnexa Therapeutics Inc ERNA.O:CELLIPONT BI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA79V0FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}